Biote Corp reports results for the quarter ended September 30 - Earnings Summary
Biote Corp reports results for the quarter ended September 30 - Earnings Summary
Biote Corp BTMD.OQ reported quarterly adjusted earnings of 1 cent per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 22 cents. The mean expectation of four analysts for the quarter was for a loss of 2 cents per share. Wall Street expected results to range from -9 cents to 4 cents per share.
Revenue fell 9.6% to $43.33 million from a year ago; analysts expected $45.07 million.
Biote Corp's reported EPS for the quarter was 1 cent.
The company reported quarterly net income of $407 thousand.
Biote Corp shares had fallen by 7.4% this quarter and lost 56.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 250% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the professional information services peer group is also "buy"
Wall Street's median 12-month price target for Biote Corp is $2.00, about 38.5% above its last closing price of $1.23
This summary was machine generated from LSEG data November 5 at 12:46 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | -0.02 | 0.01 | Beat |
Jun. 30 2026 | 0.04 | -0.21 | Missed |
Mar. 31 2026 | 0.05 | 0.06 | Beat |
Dec. 31 2025 | 0.05 | 0.06 | Beat |
Recent news on biote
See all newsBiote Corp reports results for the quarter ended September 30 - Earnings Summary
Corrected: Biote Q3 revenue falls misses analyst expectations on soft procedure segment
Biote Corp expected to post earnings of 4 cents a share - Earnings Preview
Brief: Biote Names Bob Peterson As Interim CEO
Biote Q1 revenue falls